Associated Papers
Whole-genome analysis identifies novel drivers and high-risk double-hit events in relapsed/refractory myeloma.
Ansari-Pour N et al.
Blood, 2023
36223594 (PubMed )
Supplement: BLOOD_BLD-2022-017010-mmc2.xlsx › Supplementary_Table_S2
Frequent low-level mutations of protein kinase D2 in angiolipoma.
Hofvander J et al.
The Journal of Pathology, 2017
BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis.
Rustad EH et al.
Blood Cancer Journal, 2015
25794135 (PubMed )
Supplement: bcj201524x1.xls › Sheet1
Select a paper to view details